GLPwatch

Case report: Nerve fiber regeneration in children with melanocortin 4 receptor gene mutation related obesity treated with semaglutide.

Front Endocrinol (Lausanne) · 2024

Last updated 2026-05-28

Two children with a genetic cause of obesity (a mutation in the MC4R gene) were treated with semaglutide once a week for 6 months. While their weight and blood sugar control (HbA1c) showed little change, tests revealed improvements in nerve fiber regeneration, with increases in corneal nerve fiber density (13.9% and 14.7%), corneal nerve branch density (110.2% and 58.7%), and corneal nerve fiber length (21.5% and 44.0%).

AI summary of the abstract below.

JournalFront Endocrinol (Lausanne), 2024
Citations6
Relative citation ratio1.73
NIH percentile69
Molecules semaglutide
Conditions studied Obesity

Abstract

Melanocortin 4 receptor () mutations are the commonest cause of monogenic obesity through dysregulation of neuronal pathways in the hypothalamus and prefrontal cortex that regulate hunger and satiety. also regulates neuropathic pain pathways via JNK signaling after nerve injury. We show evidence of corneal small fiber degeneration in 2 siblings carrying a heterozygous missense variant c.508A>G, p.Ille170Val in the gene. Both children were treated with once weekly semaglutide for 6 months with no change in weight, and only a minor improvement in HbA1c and lipid profile. However, there was evidence of nerve regeneration with an increase in corneal nerve fiber density (CNFD) [child A (13.9%), child B (14.7%)], corneal nerve branch density (CNBD) [child A (110.2%), child B (58.7%)] and corneal nerve fiber length (CNFL) [child A (21.5%), child B (44.0%)].

Verbatim abstract via PubMed 38974580 ↗

Related research